Your Article Summary
Genmab revises financial guidance
Genmab, 11/06/09
Genmab announced a reorganization plan in a separate stock exchange release (no.41/2009) including a contemplated reduction in headcount of approximately 300 positions and decision to sell its manufacturing facility in Brooklyn Park, Minnesota, USA. As a result, Genmab is revising its 2009 financial guidance.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Article Search
Sponsor


See All



